Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -200,973 | -56,289 | N/A | N/A |
| Depreciation Amortization | 37,964 | 25,963 | N/A | N/A |
| Accounts receivable | 3,292 | -22,123 | N/A | N/A |
| Accounts payable and accrued liabilities | -90,246 | -24,773 | N/A | N/A |
| Other Working Capital | -93,448 | -48,375 | N/A | N/A |
| Other Operating Activity | 121,051 | 56,885 | 0 | 0 |
| Operating Cash Flow | $-222,361 | $-68,711 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -43,200 | -35,304 | N/A | N/A |
| Net Acquisitions | -6,783 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -36,387 | -43,999 | N/A | N/A |
| Other Investing Activity | -36,387 | -43,998 | 0 | 0 |
| Investing Cash Flow | $-86,369 | $-79,302 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 12,320 | 6,614 | N/A | N/A |
| Common Stock Issued | 420,393 | 427,197 | N/A | N/A |
| Other Financing Activity | -3,428 | -2,537 | 0 | 0 |
| Financing Cash Flow | $429,285 | $431,274 | $N/A | $N/A |
| Exchange Rate Effect | 18 | -542 | N/A | N/A |
| Beginning Cash Position | 460,874 | 203,257 | N/A | N/A |
| End Cash Position | 581,447 | 485,976 | N/A | N/A |
| Net Cash Flow | $120,573 | $282,718 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -222,361 | -68,711 | N/A | N/A |
| Capital Expenditure | -43,223 | -36,136 | N/A | N/A |
| Free Cash Flow | -265,584 | -104,847 | 0 | 0 |